Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
3.335
-0.095 (-2.77%)
Jul 22, 2025, 3:52 PM - Market open
Anixa Biosciences Employees
As of October 31, 2024, Anixa Biosciences had 5 total employees, including 4 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,426,800
Market Cap
107.42M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ANIX News
- 7 days ago - Anixa Biosciences: Oncology Platform With Asymmetric Upside - Seeking Alpha
- 13 days ago - Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology - PRNewsWire
- 4 weeks ago - Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial - PRNewsWire
- 4 weeks ago - Anixa Biosciences to Host an Investor Webcast on June 26, 2025 - PRNewsWire
- 6 weeks ago - Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage - PRNewsWire
- 6 weeks ago - Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025 - PRNewsWire
- 7 weeks ago - Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview - PRNewsWire
- 7 weeks ago - Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine - PRNewsWire